Tilmont, R., Yakoub-Agha, I., Eikema, D., Zinger, N., Haenel, M., Schaap, N., Herrera Arroyo, C., Schuermans, C., Bethge, W., Engelhardt, M., Kuball, J., Michieli, M., Schub, N., Wilson, K. M. O., Bourhis, J. H., Mateos, M. V., Robin, N., Jost, E., Kröger, N., Moraleda, J. M., Sica, S., Hayden, P. J., Beksac, M., Schönland, S., & Manier, S. (n.d.). p957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT. HemaSphere, 6, 847–848. http://access.bl.uk/ark:/81055/vdc_100159756595.0x000011